Now we have three newer treatments for IgAN:
1) Filspari (sparsentan) - approved Feb, 2023 - $10,000 per month
2) Tarpeyo (budesonide) - approved Dec, 2023 - $15,000 per month
3) Fabhalta (iptacopan) - approved Aug, 2024 - $45,826 per month
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Hemodiafiltration versus Hemodialysis in End-Stage Kidney Disease: A Systematic Review and Meta-analysis
Authors demonstrated that patients receiving HDF experienced a reduction in all-cause mortality, CV mortality & infections-related mortality.
buff.ly/44j5taV
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
#NephMadness 2024 went live on March 1st but planning started well before that. This initiative could not happen without the #NephTwitter community - we are immensely grateful to everyone who helped us develop the content as well as everyone who participated in the tournament!
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Learn more about our kidney #xenotransplant @mgh_transplant
This short video provides an overview of the rationale, the details about the immunosuppression used, and the precautions taken in our study. Click on the second video in the video section @ leoriella.com
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Don't miss Part 2: An Expert Approach to Cardio-Renal Protection in CKD.
Thursday, 18 April, at 16:30 BST/11:30 EST.
Register for free below.
🌟Explore new cardio-renal care strategies, engage with top experts and earn 1 CME credit.
Watch our roundtable, 'An Expert Approach to Cardio-Renal Protection in #CKD: A Case Based Discussion - Part Two', live online on 18 April
🔗bit.ly/4aYLOiT
#Cardiology #CardioEd #MedEd #HeartFailure #CME #CKDManagement
This CME programme is supported by an unrestricted educational grant from AstraZeneca.
Dear colleagues,
I've transitioned to a digital health creator on Instagram (@kidneypharmacist) after losing my father to kidney disease. Join me in empowering patients and promoting kidney health. Your support is invaluable❤️@ACCP instagram.com/kidneypharmaci…
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Intradialytic hypertension is associated with cardiovascular and all-cause mortality. This study found shorter vector length was associated with higher post-HD systolic BP and risk of intradialytic hypertension bit.ly/CJASN0356
@KScovner @DrYFarag @gchertow @StanfordNeph
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
This is a great infographic by the International Society of Nephrology on the dietary approaches to hyperkalemia:
theisn.org/initiatives/toolk…
@ISNkidneycare
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
#TwitteRx -- what are YOU wanting to 👀 in future @ACCP #NephPRN CE sessions?
Tell us in a 1-minute, one question survey! 👇
uwyo.sjc1.qualtrics.com/jfe/…
Thank you Bruce for presenting our research on behalf of us!
@BAMPharmD #homehemodialysis
#Nxstage #kidneyweek
We are ready to present a whole row of our @UMichPharmacy research @ASNKidney @Kidneywk posters!
Very tragic to hear what happened in Seoul, Korea. My condolences for those who suffered cardiac arrests and passed away. Majority of people who died were women in 20s. #HalloweenSafety needs to be enforced!!
cnn.com/2022/10/29/asia/sout…
Replying to @UMichPharmacy
@UMichPharmacy @BAMPharmD Fellowship union at #ACCPG2022!
@SusanjoyLewis @NephRx
#nephrology #criticalcare #California #Ohio #Michigan #Thailand @ACCPNephro
Reunion time!!!
Had a fabulous time at #ACCPGC2 meeting with
@ACCPNephro members and presenting research with former fellows like @NephRx, @chaijamorn, and @SusanjoyLewis. It was great to be able to get together in person!
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Honored to contribute to this edition of @ASNKidney @KidneyNews focused on interprofessional nephrology care teams! We need more training programs for pharmacist specialists in this area to improve the care of our patients. @UCSDSkaggsSOP @ucsdnephrology @UCSDHealth – at San Diego, CA
Check out the full @KidneyNews Sept issue - focus on Kidney Care Team- the role of NP, PA and Pharm-Ds in Nephrology. @LAwdishu @SusanQuaggin onlinedigeditions.com/public… Kidney Medicine is a TEAM SPORT! @ASNKidney
Does patient's size matter when you are dosing antibiotics in patients receiving CRRT? Thank you @BAMPharmD for your continued mentorship!
mdpi.com/2079-6382/10/11/139…
@ACCPNephro
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Chlorthalidone reduces UACR by 50% at 12 weeks in addition to ACEI/ARB and beta blockers in advanced CKD. Amazing work Dr Agarwal! @AgarwalRajivMD #KidneyWk
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Patients with advanced CKD experience progressive declines in physical activity and function. This study shows that transition to dialysis is associated with accelerated decline in physical function measured by chair stand test bit.ly/CJN07050521
@QuantaDT
Dr. Soo Jang (aka Kidney Pharmacist) retweeted
Wanting to see research from Neph PRN members? Posters start soon!
Which posters are you most excited about? Drop answers below 👇
Catch up on the latest research in clinical pharmacy & clinical pharmacology at the FREE interactive #ACCPAM21 Scientific Poster Sessions TODAY, Oct. 19 and Wed., Oct. 20. Authors will be available for real-time, online Q&A sessions. Create an account at ow.ly/F9kD50GtsEV





























